SCYNEXIS, Inc. Gain (Loss) on Disposition of Business
SCYNEXIS, Inc. (SCYX) reported Gain (Loss) on Disposition of Business of -$73.00 thousand for the 3-month period ending 2015-09-30, per its 10-K filed 2017-03-13.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfBusiness · last filed 2017-03-13
- SCYNEXIS, Inc. gain (loss) on disposition of business for the quarter ending 2015-09-30 was -$73.00K.
| Period end | Gain (Loss) on Disposition of Business 3 month | Gain (Loss) on Disposition of Business 9 month |
|---|---|---|
| 2015-09-30 | -$73.00K 10-K · filed 2017-03-13 | -$73.00K 10-Q · filed 2015-11-13 |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |